Article Information
History
- May 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alberto Parras1,3,
- Alba Vílchez-Acosta1,3,
- Gabriela Desdín-Micó1,3,
- Calida Mrabti1,
- Cheyenne Rechsteiner1,
- Fabrice Battiston1,
- Clémence Branchina1,
- Kevin Pérez1,
- Christine Sempoux2 and
- Alejandro Ocampo1,4,*
- 1Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Vaud, Switzerland
- 2Service of Clinical Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- ↵*Correspondence: alejandro.ocampo{at}unil.ch
↵3 These authors contributed equally.
Posted May 27, 2022.
In vivo reprogramming leads to premature death due to hepatic and intestinal failure
